Research Webinar Series: Overview of Clinical Trial Participation

Presented by: Jonathan Hogan, MD
During this webinar, we will provide an overview of clinical trial participation and review Cabaletta’s CD19-Chimeric Antigen Receptor (CAR) T study for people with generalized myasthenia gravis and Cabaletta’s MuSK-CAART study for people with MuSK-positive myasthenia gravis.

[@user-ii1ni1fc8q]

I will sign up has I’ve diagnosed with mg

[@MSKESHA74]

I'm ACHR positive. How would you sign up for this triall if interested

[@myastheniagravisfoundation8053]

To find out more about clinical trials open right now, visit clinicaltrials.gov and search for "myasthenia gravis."

[@MSKESHA74]

Is it true that when you participate in clinical trials, you would have to stop all other neds?

[@myastheniagravisfoundation8053]

This depends on the trial. You can always contact the trial coordinator to ask about specifics.

[@user-pu5ys9he1z]

Can yo loose your eye sight

[@myastheniagravisfoundation8053]

myasthenia gravis can cause double or blurry vision, making it difficult to see.